ArticleCureus2025
A Perinatal Review of Prevalence and Risk Factors for Substance Abuse Among Pregnant Women in Singapore.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDrug use during pregnancy can have detrimental effects on pregnancy and can lead to poor maternal and child health outcomes. There is currently limited information available on the prevalence and risk factors for drug abuse in pregnant women in Singapore. The aims of the study are to (i) establish the prevalence of drug abuse and (ii) assess risk factors for drug abuse during pregnancy.
methodsA perinatal review of the management of cases of substance abuse in pregnancy from 2010 to 2020 was performed. Case records of substance abuse (excluding alcohol and tobacco) over the last 10 years from 2010 to 2020 were sourced via ICD-10 Diagnosis and extracted from the medical records. Essential demographic data were subsequently collected.
resultsThere was a total of 20 women with perinatal drug abuse between 2010 and 2020. Three of the 20 women engaged in drug abuse for two of their pregnancies each, making 23 pregnancies affected by substance abuse during this period. The prevalence was low at 0.018% (23/128576) or 1 in 5,590 pregnant women. The common substance abuse was heroin with 11 cases (55.0%) and amphetamines/methamphetamines with nine cases (45.0%). High-risk factors for the pregnant substance abuser were younger age < 30 years old, Malay or Indian ethnicity and a history of smoking. In general, pregnant drug abusers book late in their pregnancy and tend to have little or no proper prenatal care and to default on their pregnancy follow-ups.
conclusionThe prevalence of drug abuse among pregnant women in Singapore is low. The overall low prevalence of drug abuse nationally has contributed to low prevalence among pregnant women. Management of substance abuse in pregnancy with referrals to the appropriate multidisciplinary team for comprehensive assessment and individualized care in general have been satisfactory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.